BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23647064)

  • 21. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
    Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
    Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
    Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
    Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival.
    Bairey O; Shvidel L; Perry C; Dann EJ; Ruchlemer R; Tadmor T; Goldschmidt N
    Cancer; 2015 Sep; 121(17):2909-16. PubMed ID: 26096161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
    Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience.
    Okamoto A; Yanada M; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Tsuzuki M; Akatsuka Y; Mizuta S; Okamoto M; Emi N
    Hematology; 2013 Mar; 18(2):74-80. PubMed ID: 23320957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis.
    Pugh TJ; Ballonoff A; Rusthoven KE; McCammon R; Kavanagh B; Newman F; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):845-9. PubMed ID: 19515509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery for papillary thyroid carcinoma: is lobectomy enough?
    Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of extensive neck dissection on survival from papillary thyroid cancer.
    Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].
    Lu JB; Li XQ; Zhang PH; Zhou XY; Zhang TM; Li XM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):470-3. PubMed ID: 17845761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
    Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ
    Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
    Kuczmarski TM; Tramontano AC; Mozessohn L; LaCasce AS; Roemer L; Abel GA; Odejide OO
    Lancet Haematol; 2023 Jul; 10(7):e530-e538. PubMed ID: 37271158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung.
    Aviles A; Nambo MJ; Huerta-Guzman J; Silva L; Neri N
    Hematology; 2013 Mar; 18(2):81-4. PubMed ID: 23394581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermediate-risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long-term outcome study.
    Ballal S; Soundararajan R; Garg A; Chopra S; Bal C
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):408-16. PubMed ID: 25823589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States.
    El-Fattah MA
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):498-505.e6. PubMed ID: 28647403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
    Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
    Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
    Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
    J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant.
    Qiao W; Zhao J; Xing Y; Wang C; Wang T
    Leuk Lymphoma; 2014 Feb; 55(2):276-82. PubMed ID: 23617323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.